| __timestamp | ACADIA Pharmaceuticals Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 4101058 |
| Thursday, January 1, 2015 | 73869000 | 10763215 |
| Friday, January 1, 2016 | 99284000 | 5579049 |
| Sunday, January 1, 2017 | 149189000 | 32051299 |
| Monday, January 1, 2018 | 187163000 | 24482286 |
| Tuesday, January 1, 2019 | 240385000 | 43892589 |
| Wednesday, January 1, 2020 | 319130000 | 44505000 |
| Friday, January 1, 2021 | 239415000 | 79406000 |
| Saturday, January 1, 2022 | 361575000 | 49283000 |
| Sunday, January 1, 2023 | 351619000 | 17282730 |
Data in motion
In the competitive world of biopharmaceuticals, innovation is the lifeblood of success. Over the past decade, ACADIA Pharmaceuticals Inc. and Verona Pharma plc have demonstrated contrasting approaches to research and development (R&D) investment. From 2014 to 2023, ACADIA Pharmaceuticals consistently outpaced Verona Pharma, investing nearly seven times more in R&D on average. In 2022, ACADIA's R&D expenses peaked at approximately 362 million, marking a 500% increase from 2014. Meanwhile, Verona Pharma's highest investment was around 79 million in 2021, a significant rise from its 2014 figure but still modest compared to ACADIA. This disparity highlights ACADIA's aggressive pursuit of innovation, while Verona Pharma adopts a more conservative strategy. As the biopharma landscape evolves, these investment patterns may shape the future breakthroughs and market positions of these two companies.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Verona Pharma plc
Neurocrine Biosciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Verona Pharma plc
Research and Development Expenses Breakdown: Grifols, S.A. vs Verona Pharma plc
R&D Insights: How Verona Pharma plc and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Verona Pharma plc and Viridian Therapeutics, Inc.
ACADIA Pharmaceuticals Inc. vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: ACADIA Pharmaceuticals Inc. vs Geron Corporation
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Evotec SE